Literature DB >> 17363093

Unusual etiology of acute lung injury in a patient with acute myocardial infarction.

Martín J García-González, Alberto Domínguez-Rodríguez, Julio J Ferrer-Hita.   

Abstract

BACKGROUND: The known etiology of acute lung injury (ALI) is immensely varied and includes severe burns and trauma. Electrical and multiple defibrillation shocks can cause cutaneous burns and blunt chest trauma. The literature contains no reference to the association between ALI and cutaneous burns or blunt chest trauma secondary to defibrillation.
OBJECTIVE: To report a patient with Acute Myocardial Infarction (AMI) who developed ALI possibly due to multiple defibrillation shocks. CASE REPORT: A 51 year-old man with AMI presenting with multiple episodes of ventricular fibrillation (VF) treated with defibrillation and subsequently cutaneous burns. He developed soon afterward respiratory failure due to ALI. Cardiac failure or any known etiology of ALI was ruled out. Medical treatment included oxygen therapy, cardiac frequency control with betablockers, in addition to antiplatelet therapy. Clinical and oxymetric evolution was favourable, with resolution of the radiological infiltrates. The patient was discharged alive and in good condition at the 19th day after admission. The authors discuss possible mechanisms of ALI development by multiple defibrillation shocks.
CONCLUSIONS: In the absence of any other known etiology, multiple defibrillation shocks may have played a role in the genesis of ALI in our patient, but this remains speculative.

Entities:  

Mesh:

Year:  2007        PMID: 17363093     DOI: 10.1016/j.ijcard.2006.11.192

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  1 in total

1.  Anti-Semaphorin-7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury.

Authors:  Xiao Chen; Hailing Wang; Kui Jia; Hao Wang; Tao Ren
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.